On the stock market since 2020, it operates in the world of health and science. It has 598 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 19% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $92.6M would still be left in the vault — a solid cushion for hard times.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit power and business quality lead the class.
Debt is low and cash is strong; the finances stand solid.
The price isn’t cheap next to earnings — that’s why this grade sits in the middle.
Sales are growing strongly for its sector.
Clearly above the class average — a step short of the very top.
No real weak spot in any of the five subjects — a balanced report card.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
R&D Investment: Spending on future research is low.
The stock trades below its recent peak — about 12% off the top. A pullback, not a collapse.
Over the last 3 years, sales grew about 24% a year on average.
There is $92.6M in the vault; even if every debt were paid off, $92.6M would remain.
The company’s market value is 113 times its annual profit. Even a small disappointment could hit the price hard.
The share set aside for the future is small; the pace of new ideas may slow. Council score: 2/10.
On our five-subject report card, TALK sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”
The takeaway: TALK is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s what that quality should cost.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.